TECON(SZ:002100) Xin Lang Cai Jing·2025-09-30 02:02Core Points - TianKang Bio's stock price has increased by 15.48% year-to-date, but has seen a decline of 2.66% in the last five trading days [2] - The company reported a revenue of 8.847 billion yuan for the first half of 2025, representing a year-on-year growth of 10.68%, with a net profit of 338 million yuan, up 22.27% [2] - The company has distributed a total of 1.891 billion yuan in dividends since its A-share listing, with 598 million yuan distributed in the last three years [3] Company Overview - TianKang Bio, established on December 28, 2000, and listed on December 26, 2006, is located in Urumqi, Xinjiang, and specializes in the production and sales of biological vaccines for livestock, feed, and plant protein [2] - The revenue composition of TianKang Bio includes 32.20% from the pig breeding industry chain, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [2] - As of September 19, 2025, the number of shareholders is 62,700, a decrease of 9.64% from the previous period, with an average of 21,770 circulating shares per person, an increase of 10.67% [2] Institutional Holdings - As of June 30, 2025, the sixth largest circulating shareholder is Guotai Zhongzheng Livestock Breeding ETF, holding 15.5491 million shares, an increase of 641,000 shares from the previous period [3] - The ninth largest circulating shareholder is Harvest Agricultural Industry Stock A, holding 10.2945 million shares, an increase of 630,100 shares [3] - The tenth largest circulating shareholder is Southern Zhongzheng 1000 ETF, holding 10.0839 million shares, an increase of 1.8978 million shares [3]